Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy

BACKGROUND: In real-world clinical practice, biologics in inflammatory bowel diseases (IBD) may be discontinued for a variety of reasons, including discontinuation initiated by gastroenterologists. The aims of the study are to report outcomes after discontinuation and predictors of prognosis after a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shivaji, Uday N., Bazarova, Alina, Critchlow, Tamsin, Smith, Samuel C. L., Nardone, Olga Maria, Love, Melanie, Davis, Joanne, Ghosh, Subrata, Iacucci, Marietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162203/
https://www.ncbi.nlm.nih.gov/pubmed/34104206
http://dx.doi.org/10.1177/1756284820981216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162203/
https://www.ncbi.nlm.nih.gov/pubmed/34104206
http://dx.doi.org/10.1177/1756284820981216

Ejemplares similares